Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $2,813 | 198 | 98.9% |
| Education | $29.99 | 1 | 1.1% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Novo Nordisk Inc | $504.27 | 36 | $0 (2023) |
| Amgen Inc. | $279.66 | 20 | $0 (2023) |
| Takeda Pharmaceuticals U.S.A., Inc. | $216.98 | 13 | $0 (2022) |
| Mylan Specialty L.P. | $208.30 | 13 | $0 (2022) |
| AbbVie Inc. | $177.23 | 21 | $0 (2023) |
| PFIZER INC. | $165.51 | 11 | $0 (2023) |
| Allergan, Inc. | $150.50 | 10 | $0 (2020) |
| Abbott Laboratories | $120.48 | 7 | $0 (2023) |
| Lilly USA, LLC | $119.49 | 9 | $0 (2021) |
| GlaxoSmithKline, LLC. | $107.28 | 7 | $0 (2023) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2023 | $232.51 | 14 | Novo Nordisk Inc ($47.18) |
| 2022 | $463.56 | 28 | Abbott Laboratories ($84.69) |
| 2021 | $654.32 | 51 | Takeda Pharmaceuticals U.S.A., Inc. ($127.84) |
| 2020 | $459.49 | 35 | Novo Nordisk Inc ($156.21) |
| 2019 | $271.53 | 18 | Mylan Specialty L.P. ($50.05) |
| 2018 | $375.76 | 25 | Novo Nordisk Inc ($81.16) |
| 2017 | $386.06 | 28 | Janssen Pharmaceuticals, Inc ($63.12) |
All Payment Transactions
199 individual payment records from CMS Open Payments — Page 1 of 8
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 11/08/2023 | Abbott Laboratories | FREESTYLE LIBRE 3 (Device) | Food and Beverage | In-kind items and services | $22.12 | General |
| Category: Diabetes Care | ||||||
| 09/26/2023 | PFIZER INC. | NURTEC ODT (Drug), ZAVZPRET | Food and Beverage | In-kind items and services | $14.37 | General |
| Category: PAIN | ||||||
| 09/13/2023 | E.R. Squibb & Sons, L.L.C. | ELIQUIS (Drug) | Food and Beverage | Cash or cash equivalent | $16.91 | General |
| Category: Cardiovascular | ||||||
| 08/16/2023 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug) | Food and Beverage | In-kind items and services | $13.46 | General |
| Category: RESPIRATORY | ||||||
| 07/12/2023 | Novo Nordisk Inc | Wegovy (Drug) | Food and Beverage | In-kind items and services | $15.85 | General |
| Category: Obesity | ||||||
| 07/07/2023 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug), AREXVY, SHINGRIX | Food and Beverage | In-kind items and services | $15.96 | General |
| Category: RESPIRATORY | ||||||
| 06/15/2023 | AbbVie Inc. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $13.25 | General |
| Category: NEUROSCIENCE | ||||||
| 05/22/2023 | Bayer Healthcare Pharmaceuticals Inc. | Kerendia (Drug) | Food and Beverage | In-kind items and services | $13.73 | General |
| Category: Cardio-renal | ||||||
| 05/09/2023 | Amgen Inc. | Repatha (Biological) | Food and Beverage | In-kind items and services | $18.62 | General |
| Category: Cardiology | ||||||
| 04/05/2023 | Bayer Healthcare Pharmaceuticals Inc. | Kerendia (Drug) | Food and Beverage | In-kind items and services | $18.80 | General |
| Category: Cardio-renal | ||||||
| 03/13/2023 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug) | Food and Beverage | In-kind items and services | $16.69 | General |
| Category: RESPIRATORY | ||||||
| 02/08/2023 | Novartis Pharmaceuticals Corporation | LEQVIO (Drug) | Food and Beverage | In-kind items and services | $21.42 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 02/06/2023 | Novo Nordisk Inc | Rybelsus (Drug), Ozempic | Food and Beverage | In-kind items and services | $14.00 | General |
| Category: Diabetes | ||||||
| 01/09/2023 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus | Food and Beverage | In-kind items and services | $17.33 | General |
| Category: Diabetes | ||||||
| 12/05/2022 | E.R. Squibb & Sons, L.L.C. | ELIQUIS (Drug) | Food and Beverage | Cash or cash equivalent | $15.33 | General |
| Category: Cardiovascular | ||||||
| 10/19/2022 | Bayer HealthCare Pharmaceuticals Inc. | Kerendia (Drug) | Food and Beverage | In-kind items and services | $21.92 | General |
| Category: Cardio-renal | ||||||
| 09/09/2022 | ABBVIE INC. | QULIPTA (Drug) | Food and Beverage | In-kind items and services | $15.47 | General |
| Category: NEUROSCIENCE | ||||||
| 08/19/2022 | Amgen Inc. | Repatha (Biological) | Food and Beverage | In-kind items and services | $14.39 | General |
| Category: Cardiology | ||||||
| 08/17/2022 | Bayer HealthCare Pharmaceuticals Inc. | Kerendia (Drug) | Food and Beverage | In-kind items and services | $22.60 | General |
| Category: Cardio-renal | ||||||
| 08/09/2022 | E.R. Squibb & Sons, L.L.C. | ELIQUIS (Drug) | Food and Beverage | Cash or cash equivalent | $17.02 | General |
| Category: Cardiovascular | ||||||
| 08/05/2022 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $19.79 | General |
| Category: NEUROSCIENCE | ||||||
| 07/25/2022 | Biohaven Pharmaceutical Holding Company Ltd. | NURTEC ODT (Drug) | Food and Beverage | In-kind items and services | $18.13 | General |
| Category: PRIMARY CARE | ||||||
| 07/15/2022 | Amgen Inc. | Repatha (Biological) | Food and Beverage | In-kind items and services | $11.18 | General |
| Category: Cardiology | ||||||
| 07/05/2022 | Bayer HealthCare Pharmaceuticals Inc. | Kerendia (Drug) | Food and Beverage | In-kind items and services | $14.02 | General |
| Category: Cardio-renal | ||||||
| 06/03/2022 | Abbott Laboratories | FREESTYLE LIBRE 2 (Device) | Food and Beverage | In-kind items and services | $19.36 | General |
| Category: Diabetes Care | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 38 | 3,568 | 9,886 | $689,288 | $326,987 |
| 2022 | 39 | 4,401 | 11,586 | $854,650 | $418,619 |
| 2021 | 43 | 4,917 | 11,632 | $790,937 | $386,385 |
| 2020 | 45 | 5,616 | 12,814 | $835,540 | $375,237 |
All Medicare Procedures & Services
165 procedure records from CMS Medicare Utilization — Page 1 of 7
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99490 | Chronic care management services, first 20 minutes of clinical staff time directed by health care professional, per calendar month | Office | 2023 | 207 | 1,890 | $122,850 | $80,040 | 65.2% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 364 | 919 | $170,015 | $72,644 | 42.7% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 310 | 778 | $97,250 | $43,589 | 44.8% |
| 99457 | Management using the results of remote vital sign monitoring per calendar month, first 20 minutes | Office | 2023 | 130 | 1,070 | $80,250 | $33,941 | 42.3% |
| 99454 | Remote monitoring of physiologic parameters, initial supply of devices with daily recordings or programmed alerts transmission, each 30 days | Office | 2023 | 120 | 846 | $71,910 | $25,696 | 35.7% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2023 | 123 | 123 | $18,450 | $14,632 | 79.3% |
| 99491 | Chronic care management services for two or more chronic conditions, first 30 minutes provided personally by health care professional, per calendar month | Office | 2023 | 137 | 242 | $21,780 | $13,334 | 61.2% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2023 | 36 | 45 | $11,250 | $5,051 | 44.9% |
| 99497 | Advance care planning, first 30 minutes | Office | 2023 | 58 | 60 | $6,600 | $4,223 | 64.0% |
| 36415 | Insertion of needle into vein for collection of blood sample | Office | 2023 | 269 | 469 | $5,628 | $3,940 | 70.0% |
| 96372 | Injection of drug or substance under skin or into muscle | Office | 2023 | 171 | 362 | $14,480 | $3,370 | 23.3% |
| 99212 | Established patient office or other outpatient visit, 10-19 minutes | Office | 2023 | 56 | 88 | $7,480 | $3,355 | 44.9% |
| 80061 | Blood test, lipids (cholesterol and triglycerides) | Office | 2023 | 181 | 217 | $6,510 | $2,841 | 43.6% |
| 85025 | Complete blood cell count (red cells, white blood cell, platelets), automated test and automated differential white blood cell count | Office | 2023 | 231 | 317 | $6,340 | $2,399 | 37.8% |
| 99211 | Office or other outpatient visit for the evaluation and management of established patient that may not require presence of healthcare professional | Office | 2023 | 44 | 151 | $4,530 | $2,211 | 48.8% |
| 83036 | Hemoglobin a1c level | Office | 2023 | 124 | 228 | $6,840 | $2,145 | 31.4% |
| G0442 | Annual alcohol misuse screening, 5 to 15 minutes | Office | 2023 | 125 | 126 | $3,780 | $2,090 | 55.3% |
| 99452 | Telephone or internet referral service, 30 minutes | Office | 2023 | 72 | 88 | $4,224 | $1,940 | 45.9% |
| 80305 | Testing for presence of drug, read by direct observation | Office | 2023 | 58 | 107 | $4,815 | $1,314 | 27.3% |
| 87426 | Detection test by immunoassay technique for severe acute respiratory syndrome coronavirus | Office | 2023 | 30 | 33 | $1,320 | $1,142 | 86.6% |
| J1040 | Injection, methylprednisolone acetate, 80 mg | Office | 2023 | 85 | 124 | $2,480 | $1,052 | 42.4% |
| 87400 | Detection test by immunoassay technique for influenza virus | Office | 2023 | 27 | 60 | $2,400 | $830.70 | 34.6% |
| 99453 | Remote monitoring of physiologic parameters, initial set-up and patient education on use of equipment | Office | 2023 | 53 | 64 | $1,920 | $816.26 | 42.5% |
| 80053 | Blood test, comprehensive group of blood chemicals | Office | 2023 | 53 | 70 | $2,100 | $719.84 | 34.3% |
| 20610 | Aspiration and/or injection of fluid from large joint | Office | 2023 | 12 | 13 | $2,327 | $535.43 | 23.0% |
About Dr. Samuel Burchfield, MD
Dr. Samuel Burchfield, MD is a Family Medicine healthcare provider based in Paragould, Arkansas. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 01/26/2006. The National Provider Identifier (NPI) number assigned to this provider is 1124098587.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Samuel Burchfield, MD has received a total of $2,843 in payments from pharmaceutical and medical device companies, with $232.51 received in 2023. These payments were reported across 199 transactions from 31 companies. The most common payment nature is "Food and Beverage" ($2,813).
As a Medicare-enrolled provider, Burchfield has provided services to 18,502 Medicare beneficiaries, totaling 45,918 services with total Medicare billing of $1.5M. Data is available for 4 years (2020–2023), covering 165 distinct procedure/service records.
Practice Information
- Specialty Family Medicine
- Location Paragould, AR
- Active Since 01/26/2006
- Last Updated 01/29/2014
- Taxonomy Code 207Q00000X
- Entity Type Individual
- Practice Solo Practitioner
- NPI Number 1124098587
Products in Payments
- Ozempic (Drug) $218.53
- Yupelri (Drug) $195.22
- TRINTELLIX (Drug) $180.84
- VRAYLAR (Drug) $163.10
- Saxenda (Drug) $122.46
- NURTEC ODT (Drug) $100.98
- CHANTIX (Drug) $93.19
- Kerendia (Drug) $91.07
- Prolia (Biological) $89.22
- FREESTYLE LIBRE 2 (Device) $84.69
- EMGALITY (Drug) $82.45
- EVENITY (Biological) $73.25
- Trintellix (Drug) $73.25
- ELIQUIS (Drug) $59.58
- Repatha (Biological) $58.92
- Aimovig (Biological) $58.27
- XARELTO (Drug) $54.14
- UBRELVY (Drug) $51.44
- Brovana (Drug) $46.53
- TRELEGY ELLIPTA (Drug) $46.11
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Family Medicine Doctors in Paragould
Hetal Patel, M.d, M.D
Family Medicine — Payments: $105,450
Dr. Clarence Kemp, M.d, M.D
Family Medicine — Payments: $19,502
Dr. Vincent Lee, M.d, M.D
Family Medicine — Payments: $17,429
Dr. Leslye Mcgrath, M.d, M.D
Family Medicine — Payments: $6,005
Dr. Stacey Noel, M.d, M.D
Family Medicine — Payments: $5,929
Dr. Bobby Thompson, M.d, M.D
Family Medicine — Payments: $5,886